Search research articles
Contact Us
Filters
Showing results (121-130 of 282) with videos related to
Page
of 29
Sort By:
Journal of the National Cancer Institute
|
November 3, 2025
What matters to society when making decisions about reimbursing drugs for prostate cancer: a discrete choice experiment
Rafael Emilio De Feria Cardet, Stephen Goodall, Tracey-Lea Laba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2008
Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer
John R Zalcberg, Lee S Rosen, Ehtesham Abdi, et al.
Internal Medicine Journal
|
March 12, 2021
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Arun A Azad, Ben Tran, Ian D Davis, et al.
Pigment Cell & Melanoma Research
|
March 27, 2013
The Ludwig institute for cancer research Melbourne melanoma cell line panel
Andreas Behren, Matthew Anaka, Pu-Han Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2005
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy
Ian D Davis, Lynette Kiers, Lachlan MacGregor, et al.
European Journal of Immunology
|
November 6, 2012
Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects
Oliver Klein, Lisa M Ebert, Damien Zanker, et al.
BJU International
|
November 3, 2012
The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer
Sue M Evans, Jeremy L Millar, Julie M Wood, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 2010
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate
Suzanne Svobodová, Judy Browning, Duncan MacGregor, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2011
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy
Joe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.
BJU International
|
October 12, 2018
Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study
Victoria M White, David J T Marco, Damien Bolton, et al.
Page
of 29
Search research articles
Search
Showing results (121-130 of 282) with videos related to
Sort By:
Page
of 29
Journal of the National Cancer Institute
|
November 3, 2025
What matters to society when making decisions about reimbursing drugs for prostate cancer: a discrete choice experiment
Rafael Emilio De Feria Cardet, Stephen Goodall, Tracey-Lea Laba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2008
Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer
John R Zalcberg, Lee S Rosen, Ehtesham Abdi, et al.
Internal Medicine Journal
|
March 12, 2021
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Arun A Azad, Ben Tran, Ian D Davis, et al.
Pigment Cell & Melanoma Research
|
March 27, 2013
The Ludwig institute for cancer research Melbourne melanoma cell line panel
Andreas Behren, Matthew Anaka, Pu-Han Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2005
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy
Ian D Davis, Lynette Kiers, Lachlan MacGregor, et al.
European Journal of Immunology
|
November 6, 2012
Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects
Oliver Klein, Lisa M Ebert, Damien Zanker, et al.
BJU International
|
November 3, 2012
The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer
Sue M Evans, Jeremy L Millar, Julie M Wood, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 2010
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate
Suzanne Svobodová, Judy Browning, Duncan MacGregor, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2011
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy
Joe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.
BJU International
|
October 12, 2018
Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study
Victoria M White, David J T Marco, Damien Bolton, et al.
Page
of 29